Oral administration traditional Chinese medicine composition for treating tuberculosis

Abstract

The invention discloses an oral administration pharmaceutical composition for treating phthisis, wherein the active constituents include the following raw material herbs (by weight portion): donkey-hide gelatin 35g, astragalus root 20g, root of pilose asiabell 25g, poria cocos wolf 15g, Chinese yam 20g, lotus seed 12g, adenophora root 25g, ophiopogon root 25g, Sichuan fritillary bulb 12g, roor of sessile stemona 25g, white atractylodes rhizome 15g and mahonia stem 12g.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for oral administration for treating pulmonary tuberculosis, which belongs to the field of traditional Chinese medicines. Background technique [0002] Tuberculosis is an inflammatory reaction caused by Mycobacterium tuberculosis invading the lungs through respiratory infection. Mycobacterium tuberculosis usually colonizes the respiratory bronchioles or alveoli and is transmitted from one person to another by inhalation of carrier droplets; it can also be transmitted from the gastrointestinal tract by drinking contaminated, unpasteurized milk Enters the human body, occasionally through skin lesions. Its basic pathological changes include exudation, proliferation and deterioration. When the body's immunity is enhanced and under the treatment of antibacterial drugs, the lesion can gradually heal. [0003] It belongs to the category of "pulmonary tuberculosis" in traditional Chinese me...

AI Technical Summary

Problems solved by technology

However, its curative effect is slow, the course of treatment is long, the cost is high, and chemotherapy has great side effects on patients, and it also damages the patient's body while being cured.